GLP-1 receptor agonist widely studied for appetite suppression and metabolic regulation.
Semaglutide is a long-acting GLP-1 receptor agonist that has become a cornerstone in metabolic research. It mimics the incretin hormone GLP-1, leading to reduced appetite, improved glycemic control, and significant weight loss in studies.
| Purity | ≥99% |
| Grade | Pharma |
| Form | Lyophilized powder |
| Volume | 3ml vial |
For laboratory research purposes only. Not for human consumption.